BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 25563490)

  • 1. Morphology and immunophenotype of canine cutaneous histiocytic tumours with particular emphasis on diagnostic application.
    Paździor-Czapula K; Rotkiewicz T; Otrocka-Domagała I; Gesek M; Śmiech A
    Vet Res Commun; 2015 Mar; 39(1):7-17. PubMed ID: 25563490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical expression of E-cadherin does not distinguish canine cutaneous histiocytoma from other canine round cell tumors.
    Ramos-Vara JA; Miller MA
    Vet Pathol; 2011 May; 48(3):758-63. PubMed ID: 21285383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The class A macrophage scavenger receptor CD204 is a useful immunohistochemical marker of canine histiocytic sarcoma.
    Kato Y; Murakami M; Hoshino Y; Mori T; Maruo K; Hirata A; Nakagawa TL; Yanai T; Sakai H
    J Comp Pathol; 2013 Feb; 148(2-3):188-96. PubMed ID: 22901707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of histiocytic diseases of dogs and cats.
    Moore PF
    Vet Pathol; 2014 Jan; 51(1):167-84. PubMed ID: 24395976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic immunohistochemistry for canine cutaneous round cell tumours - retrospective analysis of 60 cases.
    Pazdzior-Czapula K; Mikiewicz M; Gesek M; Zwolinski C; Otrocka-Domagala I
    Folia Histochem Cytobiol; 2019; 57(3):146-154. PubMed ID: 31553052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical Labeling of Multiple Myeloma Oncogene 1/Interferon Regulatory Factor 4 (MUM1/IRF-4) in Canine Cutaneous Histiocytoma.
    Stilwell JM; Rissi DR
    Vet Pathol; 2018 Jul; 55(4):517-520. PubMed ID: 29444632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical and histochemical stains for differentiating canine cutaneous round cell tumors.
    Fernandez NJ; West KH; Jackson ML; Kidney BA
    Vet Pathol; 2005 Jul; 42(4):437-45. PubMed ID: 16006603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical expression of ionized calcium binding adapter molecule 1 in cutaneous histiocytic proliferative, neoplastic and inflammatory disorders of dogs and cats.
    Pierezan F; Mansell J; Ambrus A; Rodrigues Hoffmann A
    J Comp Pathol; 2014 Nov; 151(4):347-51. PubMed ID: 25172051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitosis and apoptosis in canine cutaneous histiocytoma and transmissible venereal tumour.
    Guvenc T; Haligur M; Orman MN; Haziroglu R
    Acta Vet Hung; 2002; 50(3):315-21. PubMed ID: 12237973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous histiocytic sarcoma with E-cadherin expression in a Pembroke Welsh Corgi dog.
    Hirako A; Sugiyama A; Sakurai M; Ozaki K; Sakai H; Takeuchi T; Morita T; Moore PF
    J Vet Diagn Invest; 2015 Sep; 27(5):589-95. PubMed ID: 26330395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localized and disseminated histiocytic sarcoma of dendritic cell origin in dogs.
    Affolter VK; Moore PF
    Vet Pathol; 2002 Jan; 39(1):74-83. PubMed ID: 12102221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canine cutaneous histiocytoma is an epidermotropic Langerhans cell histiocytosis that expresses CD1 and specific beta 2-integrin molecules.
    Moore PF; Schrenzel MD; Affolter VK; Olivry T; Naydan D
    Am J Pathol; 1996 May; 148(5):1699-708. PubMed ID: 8623937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histiocytic Diseases.
    Moore PF
    Vet Clin North Am Small Anim Pract; 2023 Jan; 53(1):121-140. PubMed ID: 36270835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PCR-based clonality analysis of antigen receptor gene rearrangements in canine cutaneous plasmacytoma.
    Takanosu M; Okada K; Kagawa Y
    Vet J; 2018 Nov; 241():31-37. PubMed ID: 30340657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E-cadherin expression in canine cutaneous histiocytomas.
    Baines SJ; McInnes EF; McConnell I
    Vet Rec; 2008 Apr; 162(16):509-13. PubMed ID: 18424847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphology and immunoreactivity of canine and feline extramedullary plasmacytomas.
    Mikiewicz M; Otrocka-Domagała I; Paździor-Czapula K; Gesek M
    Pol J Vet Sci; 2016; 19(2):345-52. PubMed ID: 27487508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canine epitheliotropic cutaneous T-cell lymphoma: an investigation of T-cell receptor immunophenotype, lesion topography and molecular clonality.
    Moore PF; Affolter VK; Graham PS; Hirt B
    Vet Dermatol; 2009 Oct; 20(5-6):569-76. PubMed ID: 20178496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA in situ hybridisation as a molecular diagnostic technique targeting IBA-1 and CD204 in canine histiocytic sarcoma.
    Engelien JL; Lejeune AT; Dark MJ; Milner RJ; Shiomitsu K
    Vet Med Sci; 2022 Jul; 8(4):1400-1408. PubMed ID: 35339118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical detection of multiple myeloma 1/interferon regulatory factor 4 (MUM1/IRF-4) in canine plasmacytoma: comparison with CD79a and CD20.
    Ramos-Vara JA; Miller MA; Valli VE
    Vet Pathol; 2007 Nov; 44(6):875-84. PubMed ID: 18039900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canine lymphomas: association of classification type, disease stage, tumor subtype, mitotic rate, and treatment with survival.
    Valli VE; Kass PH; San Myint M; Scott F
    Vet Pathol; 2013 Sep; 50(5):738-48. PubMed ID: 23444036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.